[Therapeutic efficacy of compound Xuanju capsule on type III prostatitis].

Abstract

OBJECTIVE:

To evaluate the therapeutic effect of Compound Xuanju Capsule on type III prostatitis.

METHODS:

A total of 242 patients with type III prostatitis diagnosed by the NIH criteria were randomly divided into an experimental and a control group of equal number, the former treated with Compound Xuanju Capsule + Tamsulosin Hydrochloride, and the latter with Quinolinone antibiotics + Tamsulosin and Hydrochloride, both for 6 months. After treatment, we assessed the therapeutic effects based on the NIH-CPSI scores and the improvement of relevant complications.

RESULTS:

All the 242 patients completed the treatment. The total effectiveness rate was 77.69% (94/121) in the experimental group, 71.56% (78/109) in those with complications. In comparison, it was only 47.10% (57/121) in the control group, 31.78% (34/107) in those with complications. Both the NIH-CPSI scores and the improvement of complications were significantly higher in the experimental than in the control group (P < 0.05).

CONCLUSION:

Compound Xuanju Capsule has a good therapeutic effect on type III prostatitis.

• Authors: Guang-Ping Peng, De-Zhu Qi, Ke-Qing Hu, Zeng-Yi Liu, Pei-Geng Wang
• Journal: Zhonghua nan ke xue = National journal of andrology (Zhonghua Nan Ke Xue) Vol. 19 Issue 6 Pg. 551-4 (Jun 2013) ISSN: 1009-3591 [Print] China
• PMID: 23862237 (Publication Type: English Abstract, Journal Article, Randomized Controlled Trial)

Chemical References

• Drugs, Chinese Herbal

Topics

• Adolescent
• Adult
• Drugs, Chinese Herbal (therapeutic use)
• Humans
• Male
• Middle Aged
• Phytotherapy
• Prostatitis (drug therapy)
• Treatment Outcome
• Young Adult